Physician profile
James Hall
NPI 1336437359
$36,494.67
in general payments reported to CMS, 2019-2025
32 companies · $5,264 in 2025
The $5,264 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,923 · 2020: $1,799 · 2021: $1,367 · 2022: $1,589 · 2023: $765 · 2024: $21K · 2025: $5,264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $22K · Food and Beverage: $5,009.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $21,806.22 |
| Food and Beverage | $5,009.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17,276.78 | 2019-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Medtronic Vascular, INC. | $5,675.38 | 2019-2020 | |
| Abbott Laboratories | $3,531.52 | 2021-2025 | Cardiomems, Mitraclip |
| Boston Scientific Corporation | $3,052.30 | 2019-2025 | Versacross Access Solution, Watchman Access System |
| Edwards Lifesciences Corporation | $2,341.90 | 2020-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Shockwave Medical, INC | $1,322.95 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $468.19 | 2020-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $376.42 | 2019-2022 | |
| Amgen INC. | $329.07 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $295.72 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $264.33 | 2019-2022 | |
| Atricure, INC. | $255.78 | 2021-2024 | |
| Abiomed | $227.74 | 2024-2025 | Impella |
| Penumbra, INC. | $193.35 | 2020-2023 | Smart Coil, Indigo System |
| Pfizer INC. | $107.76 | 2022-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $97.90 | 2022-2023 | Zio Xt Patch |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.23 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $90.93 | 2022 | |
| Amarin Pharma, INC. | $64.93 | 2019-2021 | |
| Heartflow, INC. | $64.23 | 2025 | |
| Aurinia Pharma U.S., INC. | $63.03 | 2021-2022 | |
| Stryker Corporation | $58.05 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $46.42 | 2022-2024 | (5044) Mcot |
| Chiesi USA, INC. | $32.60 | 2020-2021 | |
| Impulse Dynamics (USA) INC. | $27.37 | 2025 | Optimizer |
| Bayer Healthcare Pharmaceuticals INC. | $25.92 | 2022 | |
| Astellas Pharma US INC | $23.34 | 2020 | |
| Portola Pharmaceuticals, LLC | $21.99 | 2019 | |
| Novo Nordisk INC | $17.69 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $17.33 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $13.60 | 2019 | |
| Cvrx, INC. | $12.92 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.